Legal Representation
Attorney
Marjorie Witter Norman
USPTO Deadlines
Next Deadline
1519 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-05)
Due Date
September 05, 2029
Grace Period Ends
March 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
40 events| Date | Code | Type | Description |
|---|---|---|---|
| Sep 5, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Sep 5, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jul 29, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Jul 28, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Jun 27, 2023 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
| Jun 27, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| May 31, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| May 18, 2023 | INCD | O | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST |
| May 17, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Apr 26, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Apr 26, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED |
| Apr 26, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
| Apr 26, 2023 | IUAF | S | USE AMENDMENT FILED |
| Dec 23, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Dec 21, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 21, 2022 | EXT1 | S | SOU EXTENSION 1 FILED |
| Dec 21, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Nov 17, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Nov 17, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Nov 17, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 28, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jun 23, 2022 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| May 3, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 3, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 13, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 30, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 25, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 24, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 24, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Nov 16, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Nov 16, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Nov 16, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Nov 16, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Nov 16, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Sep 24, 2021 | CPRA | R | PRIORITY ACTION WRITTEN |
| Sep 24, 2021 | GPRA | F | PRIORITY ACTION E-MAILED |
| Sep 24, 2021 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Sep 13, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Jun 9, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 12, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 041
Providing a website featuring non-downloadable articles in the field of pharmaceutical and therapeutic treatments for infusion patients; providing a website featuring non-downloadable articles in the field of nursing care for infusion patients
First Use Anywhere:
Jan 3, 2019
First Use in Commerce:
Jan 3, 2019
Class 044
Providing a website featuring health and medical information relating to pharmaceutical and therapeutic treatments for infusion patients; providing a website featuring information relating to nursing care services for infusion patients
First Use Anywhere:
Jan 3, 2019
First Use in Commerce:
Jan 3, 2019
Additional Information
Design Mark
The mark consists of the word "NUFACTOR" in small-case stylized letters above the words "A SPECIALTY INFUSION COMPANY" in large-case stylized letters.
Classification
International Classes
041
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"A SPECIALTY INFUSION COMPANY"